Status:

COMPLETED

The Effect of Exercise on Gut Microbiota in Type 2 Diabetic Patients

Lead Sponsor:

Amsterdam UMC, location VUmc

Collaborating Sponsors:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions:

Type 2 Diabetes Mellitus

Insulin Sensitivity/Resistance

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

To investigate whether targeted lifestyle intervention (exercise), induces a change in intestinal fecal microbiota related to improved glycemic control and systemic inflammation in patients with DM ty...

Detailed Description

Diet and exercise are the most beneficial lifestyle interventions in patients with diabetes mellitus (DM) type 2, causing an increase in glucose tolerance. One of the mechanisms through which these t...

Eligibility Criteria

Inclusion

  • Subjects must meet the criteria for diabetes type 2 (a random blood sugar of \> 11.1 mmol/L and/or a fasting blood sugar lever of \>7.0 mmol/L and/or a blood sugar of \>11.1 mmol/L two hours after an oral glucose tolerance test and/or an HbA1c level of \>47 mmol/mol).
  • Male or female (post-menopausal)
  • Age above 45 years and below 70 years
  • BMI \>30 kg/m2
  • HbA1c \< 80 mmol/mol or \< 8,6% Subjects must use metformin
  • Stable medication use
  • Stable tension regulation (with or without medication)
  • Subjects should be able to give informed consent

Exclusion

  • A history of cardiovascular event (Cerebrovascular event, myocardial infarction or pacemaker implantation)
  • Severe-very severe lung emphysema (GOLD stage III-IV)
  • Use of any antibiotics or proton pump inhibitor (PPI) in the past three months
  • Use of any other antidiabetic medication besides metformin (e.g. SU-derivates, insulin)
  • Use of a platelet inhibitor or cumarin derivate during
  • Subjects participated in a lifestyle programme in the past 6 months (diet or exercise)

Key Trial Info

Start Date :

May 11 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 29 2017

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT03380338

Start Date

May 11 2016

End Date

June 29 2017

Last Update

June 3 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

VU University Medical Center

Amsterdam, North Holland, Netherlands, 1081 HV